Skip to main content
SpringerLink
Log in

ADR burden in patients receiving biologicals for IMIDs

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • van Lint JA, et al. Patient-Reported Burden of Adverse Drug Reactions Attributed to Biologics Used for Immune-Mediated Inflammatory Diseases. Drug Safety : 25 May 2020. Available from: URL: https://doi.org/10.1007/s40264-020-00946-z

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

ADR burden in patients receiving biologicals for IMIDs. Reactions Weekly 1807, 7 (2020). https://doi.org/10.1007/s40278-020-79293-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-79293-y

Search

Navigation